Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.90
-0.47 (-6.38%)
At close: May 15, 2026, 4:00 PM EDT
7.02
+0.12 (1.74%)
After-hours: May 15, 2026, 7:27 PM EDT
Sagimet Biosciences Employees
Sagimet Biosciences had 16 employees as of December 31, 2025. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,719,500
Market Cap
426.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 2 | 14.29% | 16 | 0 |
| Dec 31, 2024 | 14 | 4 | 40.00% | 14 | 0 |
| Dec 31, 2023 | 10 | 0 | - | 8 | 2 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2020 | 7 | - | - | 6 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyell Immunopharma | 300 |
| ADC Therapeutics | 193 |
| Ocugen | 116 |
| Prelude Therapeutics | 79 |
| Upstream Bio | 75 |
| PureTech Health | 56 |
| Fulcrum Therapeutics | 55 |
| Eupraxia Pharmaceuticals | 49 |
SGMT News
- 3 days ago - Sagimet Biosciences price target lowered to $28 from $37 at Clear Street - TheFly
- 4 days ago - Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 5 days ago - Sagimet Biosciences reports Q1 EPS (33c), consensus (35c) - TheFly
- 5 days ago - Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 6 days ago - Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago - GlobeNewsWire
- 13 days ago - Sagimet Biosciences price target raised to $49 from $28 at Canaccord - TheFly
- 15 days ago - Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer - TheFly
- 16 days ago - Sagimet Biosciences Transcript: Status update - Transcripts